Not applicableWithdrawnNCT02298647What this trial is testingBiomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)Who this might be right forHepato-splenomegalyDysostosis MultiplexSeizures+1 more CENTOGENE GmbH Rostock
Not applicableLooking for participantsNCT00668187What this trial is testingA Natural History Study of the GangliosidosesWho this might be right forTay-Sachs DiseaseSandhoff DiseaseLate Onset Tay-Sachs Disease+2 more University of Minnesota 52
Testing effectiveness (Phase 2)Study completedNCT05758922What this trial is testingPhase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZ-3102 in Patients With GM2 Gangliosidosis or Niemann-Pick Type C DiseaseWho this might be right forGM2 GangliosidosisNiemann-Pick Disease, Type C Azafaros B.V. 13
Not applicableStudy completedNCT01869270What this trial is testingGene Therapy for Tay-Sachs DiseaseWho this might be right forTay Sachs DiseaseSandhoff DiseaseLate Onset Tay Sachs Disease University of Minnesota 4
Not applicableStudy completedNCT02699190What this trial is testingLeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for LeukodystrophiesWho this might be right forLeukodystrophyWhite Matter Disease4H Syndrome+61 more Children's Hospital of Philadelphia 236
Not applicableEnrolling By InvitationNCT05368038What this trial is testingScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramWho this might be right forAcid Sphingomyelinase DeficiencyCeroid Lipofuscinosis, Neuronal, 2Cerebrotendinous Xanthomatosis+11 more Albert Einstein College of Medicine 100,000
Not applicableLooking for participantsNCT03333200What this trial is testingLongitudinal Study of Neurodegenerative DisordersWho this might be right forMLDKrabbe DiseaseALD+24 more University of Pittsburgh 1,500
Not applicableStudy completedNCT05109793What this trial is testingGM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)Who this might be right forGM1 GangliosidosisSandhoff DiseaseTay-Sachs Disease Azafaros B.V. 31
Testing effectiveness (Phase 2)Looking for participantsNCT07399704What this trial is testingEvaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C DiseaseWho this might be right forGM2 GangliosidosisNiemann-Pick Type C Disease Azafaros B.V. 21
Testing effectiveness (Phase 2)Study completedNCT03759665What this trial is testingN-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)Who this might be right forGM2 GangliosidosisTay-Sachs DiseaseSandhoff Disease IntraBio Inc 30